Commencement of Share Buyback Programme

Summary by AI BETAClose X

3i Group plc has announced a share buyback programme of up to £750 million, commencing on 14 May 2026 and concluding by 31 December 2026. The company has engaged Barclays Bank PLC to execute market purchases of its ordinary shares, which will then be cancelled to reduce share capital. The programme is initially authorised to purchase up to 97,000,000 shares, with a potential renewal sought at the 2026 Annual General Meeting. All repurchases will adhere to regulatory requirements, and any purchases will be announced within seven daily market sessions.

Disclaimer*

3i Group PLC
14 May 2026
 

 

 

This announcement contains inside information for the purposes of Article 7 of the UK version of the EU Market Abuse Regulation (596/2014). Upon the publication of this announcement, this information is considered to be in the public domain.

 

3i Group plc to commence share buyback programme of up to £750 million

 

3i Group plc ("3i" or the "Company") announces that it will commence a share buyback programme of its ordinary shares of 73 19/22p each ("Shares") for up to a maximum aggregate consideration of £750 million (the "Programme").

The Programme will commence on 14 May 2026 and complete by no later than 31 December 2026. 3i has entered into an arrangement with Barclays Bank PLC, acting through its investment bank (the "Broker") to undertake the Programme by making market purchases, as riskless principal, of the Shares on the London Stock Exchange or another recognised investment exchange (the "Agreement").

The Broker will make trading decisions under the Programme independently of 3i, subject to certain parameters agreed between the Broker and 3i prior to the commencement of the Programme and to 3i's right to terminate the Agreement.

Shares acquired by the Broker will subsequently be sold on to 3i and will be cancelled. The purpose of the Programme is therefore to reduce 3i's share capital. 

Prior to the Company's 2026 Annual General Meeting (the "2026 AGM"), the maximum number of Shares that can be purchased under the Programme is 97,000,000 Shares as authorised by shareholders at the Company's 2025 Annual General Meeting on 26 June 2025 (the "Existing Authority"). The Existing Authority will expire at the earlier of 25 September 2026 or the 2026 AGM, where the Company expects to seek renewal of the Existing Authority (the "Renewed Authority"). The continuation of the Programme following the 2026 AGM is subject to approval of the Renewed Authority and purchases of Shares pursuant to the Programme remaining within the Renewed Authority (if applicable).

Any purchase of Shares under the Programme will be executed in accordance with the Existing Authority and any subsequent authority, the Market Abuse Regulation 596/2014 and the Commission Delegated Regulation (EU) 2016/1052 (both as incorporated into UK domestic law by the European Union (Withdrawal) Act 2018), and Chapter 9 of the Financial Conduct Authority's UK Listing Rules.

Repurchases of Shares under the Programme will be announced by no later than the end of the seventh daily market session following the calendar day on which the relevant repurchase occurred.

 

 

For further information, contact:

 

3i Group plc

 

Silvia Santoro

Investor enquiries

 

Kathryn van der Kroft

Media enquiries

 

 

 

Tel: +44 20 7975 3258

Email: silvia.santoro@3i.com

 

Tel: +44 20 7975 3021

Email: kathryn.vanderkroft@3i.com

 

Legal Entity Identifier: 35GDVHRBMFE7NWATNM84

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 

Companies

3i Group (III)
UK 100

Latest directors dealings